Our Investment Focus
Colorcon Ventures invests in and supports entrepreneurs developing transformational pharmaceutical and nutraceutical industry solutions, through strategic relationships that create value for both Colorcon and our portfolio companies.
Our Investment Focus
Investment in innovative pharmaceutical and nutraceutical industry solutions including:
- Technologies to improve patient compliance and medication adherence
- Solutions to authenticate dosage forms and reduce impact of diversion and counterfeiting of medications
- Transformational technologies disrupting conventional dosage delivery pathways
- Smart technologies for digital and personalized medicines
- Breakthrough technologies and advanced manufacturing processes
- Other intelligent solutions to address unmet needs in pharmaceutical technology or supply chains
Value Added Investment Services: In addition to initiating commercial discussions, Colorcon Ventures helps our portfolio companies grow through consultation on sales and scientific development.
Note: We are currently not investing in active pharmaceutical ingredient (API) or therapeutic molecule development
Stage
- We are stage agnostic, but primarily focused on early and mid-stage investments
Size
- $50 million fund
- Typical investment size: $1-3 million initial investment
- We reserve capital for future financing rounds
- We typically co-invest with top-tier venture capital investors
